KI 3315

Drug Profile

KI 3315

Latest Information Update: 22 Sep 2004

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Kirin Brewery
  • Class Pyridines; Vasodilators
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Myocardial ischaemia

Most Recent Events

  • 22 Sep 2004 Discontinued - Preclinical for Myocardial ischaemia in Japan (unspecified route)
  • 25 May 1995 Investigation in Myocardial ischaemia in Japan (Unknown route)
  • 17 Oct 1994 Preclinical development for Myocardial ischaemia in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top